ClinicalTrials.gg
Not yet recruitingNCT07896447ICU-RESILIENCEUpdated Oct 27, 2026

Mobile-Based Resilience Intervention for Moral Injury, Compassion Fatigue, and Distress in ICU Nurses

An interventional study of Behavioral in Moral Injury, sponsored by Alexandria University. Not yet recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Alexandria University · Not applicable, Interventional, and Prevention

Updated Oct 27, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Critical care nurses are routinely exposed to high acuity, mortality, end-of-life decisions, and long rotating shifts, which can lead to moral injury, compassion fatigue (burnout and secondary traumatic stress), and psychological distress. This randomized controlled trial will test the effectiveness of ICU Resilience, an 8-week, self-paced, Arabic-language mobile-based workplace resilience intervention, in reducing these outcomes among full-time nurses working in the intensive care units of Beni-Suef University Hospitals, Egypt.

One hundred sixty nurses will be randomly allocated 1:1 to the intervention or a control arm. The intervention is grounded in Conservation of Resources theory and an integrated cognitive-reappraisal and psycho-spiritual resilience framework, organized around psychological, emotional, social, and professional resources. Each weekly module includes a micro-learning video, an audio-guided exercise, an interactive digital tool, and a daily one-minute micro-practice, covering psychoeducation, mindfulness and somatic regulation, cognitive reappraisal, self-compassion, meaning-making, social support, practical coping, and relapse prevention. Control participants receive usual workplace orientation and routine hospital support and are offered the app after the final assessment.

Moral injury, burnout, secondary traumatic stress, psychological distress, and resilience will be measured with self-report scales at baseline, immediately after the intervention (week 8), and at one-month follow-up (week 12).

02

Conditions studied

  • Moral Injury

Keywords

  • Mobile health
03

In context

Stress Disorders, Post-Traumatic

2,291 studies on the registry are indexed under Stress Disorders, Post-Traumatic; 559 are open to participants now.

This study's planned enrollment of 160 is above the median of 70 across 1,903 interventional studies indexed under Stress Disorders, Post-Traumatic.

Browse Stress Disorders, Post-Traumatic studies →

Lead sponsor

Alexandria University is the lead sponsor of 596 studies on the registry; 134 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Currently working as a full-time staff nurse in one of the study intensive care units (General, Trauma, Neurosurgical, Medical, or Chest ICU) of Beni-Suef University Hospitals for at least 6 months.
  • Owns and routinely uses a smartphone.
  • Willing to download and engage with the mobile application.
  • Written informed consent.

Exclusion criteria

Exclusion Criteria:

  • Extended leave (sick or maternity) overlapping the 12-week trial window.
  • Current receipt of formal psychotherapy or psychotropic medication.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
160 participants (estimated)

Study arms

  • Experimental
    ICU Resilience App

    Participants use the ICU Resilience mobile application for 8 consecutive weeks (one module per week plus daily one-minute micro-practices) in addition to usual workplace orientation and routine hospital support.

    Behavioral: Behavioral

  • No intervention
    Usual Support Control

    Participants receive usual workplace orientation and routine hospital support, with no access to the app during the trial. They complete the same assessments at the same time points and are offered the app after the follow-up assessment.

Interventions

  • BehavioralBehavioral

    Eight weekly modules delivered individually and asynchronously through a web-based mobile application in Arabic, with no facilitator. Each module includes a micro-learning video (5-7 minutes), an audio-guided exercise (3-10 minutes), an interactive digital tool, and a daily 1-minute micro-practice. Weekly topics: psychoeducation; mindfulness and somatic regulation; cognitive reappraisal; self-compassion and emotion regulation; meaning-making and values; social support; practical coping and shift micro-drills; integration and relapse prevention. Grounded in Conservation of Resources theory and a cognitive-reappraisal and psycho-spiritual resilience framework. Automated reminders prompt module and daily practice completion.

06

What researchers measure

Primary outcomes

  1. Moral injury: Moral Injury Symptom Scale-Healthcare Professionals (MISS-HP) total score

    Moral injury symptoms measured with the Moral Injury Symptom Scale-Healthcare Professionals (MISS-HP; Mantri et al., 2020), a 10-item self-report questionnaire. Items are rated from 1 (strongly disagree) to 10 (strongly agree); items 5, 6, 7, and 10 are reverse-coded. Minimum total score 10, maximum 100. Higher scores indicate greater moral injury (worse outcome). Unit of measure: score on a scale.

    Time frame: Baseline (T0), immediately after the 8-week intervention (T1, week 8), and one-month follow-up (T2, week 12)

  2. urnout: Professional Quality of Life Scale version 5 (ProQOL-5), Burnout subscale score

    Burnout measured with the 10-item Burnout subscale of the Professional Quality of Life Scale version 5 (ProQOL-5; Stamm, 2009), one of two subscales used to operationalize compassion fatigue. Items are rated from 1 (never) to 5 (very often) for the past 30 days; items 1, 4, 15, 17, and 29 are reverse-scored. Minimum subscale score 10, maximum 50. Higher scores indicate greater burnout (worse outcome). Unit of measure: score on a scale.

    Time frame: Baseline (T0), immediately after the 8-week intervention (T1, week 8), and one-month follow-up (T2, week 12)

  3. Secondary traumatic stress: Professional Quality of Life Scale version 5 (ProQOL-5), Secondary Traumatic Stress subscale score

    Secondary traumatic stress measured with the 10-item Secondary Traumatic Stress subscale of the Professional Quality of Life Scale version 5 (ProQOL-5; Stamm, 2009), one of two subscales used to operationalize compassion fatigue. Items are rated from 1 (never) to 5 (very often) for the past 30 days. Minimum subscale score 10, maximum 50. Higher scores indicate greater secondary traumatic stress (worse outcome). Unit of measure: score on a scale.

    Time frame: Baseline (T0), immediately after the 8-week intervention (T1, week 8), and one-month follow-up (T2, week 12)

  4. Psychological distress: Kessler Psychological Distress Scale (K10) total score

    Non-specific psychological distress (anxiety and depressive symptoms) measured with the Kessler Psychological Distress Scale (K10; Kessler et al., 2002), a 10-item self-report questionnaire covering the preceding four weeks. Items are rated from 1 (none of the time) to 5 (all of the time). Minimum total score 10, maximum 50. Higher scores indicate greater psychological distress (worse outcome). Unit of measure: score on a scale.

    Time frame: Baseline (T0), immediately after the 8-week intervention (T1, week 8), and one-month follow-up (T2, week 12)

Secondary outcomes

  1. Resilience: 10-item Connor-Davidson Resilience Scale (CD-RISC-10) total score

    Resilience measured with the 10-item Connor-Davidson Resilience Scale (CD-RISC-10; Campbell-Sills and Stein, 2007), a self-report questionnaire covering the past month. Items are rated from 0 (not true at all) to 4 (true nearly all the time). Minimum total score 0, maximum 40. Higher scores indicate greater resilience (better outcome). Unit of measure: score on a scale.

    Time frame: Baseline (T0), immediately after the 8-week intervention (T1, week 8), and one-month follow-up (T2, week 12)

07

Study locations

1 site
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07896447
Responsible party
Mohamed Fakhry Ahmed Salem (Dr, Alexandria University) — Principal investigator
First posted
Oct 27, 2026
Start date
Oct 2026 (estimated)
Primary completion
Nov 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Oct 27, 2026

Study contacts

Mohamed Fakhry Salem, PhD
Contact
Mohamed.Fakhry@alexu.edu.eg
01286038014
Mohamed Fakhry Salem, PHD
principal investigator · Alexandria University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion